Search research articles
Contact Us
Filters
Showing results (61-70 of 85) with videos related to
Page
of 9
Sort By:
Nature Communications
|
March 7, 2024
CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expression
Huiqiang Cai, Bin Zhang, Johanne Ahrenfeldt, et al.
Nature Biotechnology
|
June 30, 2015
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
Ayal Hendel, Rasmus O Bak, Joseph T Clark, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 15, 2018
Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34<sup>+</sup> Hematopoietic Stem and Progenitor Cells
M Kyle Cromer, Sriram Vaidyanathan, Daniel E Ryan, et al.
Nucleic Acids Research
|
August 14, 2025
Gene editing in hematopoietic stem cells by co-delivery of Cas9/sgRNA ribonucleoprotein and templates for homology-directed repair in 'all-in-one' lentivirus-derived nanoparticles
Sofie Andersen, Jonas Holst Wolff, Thomas Wisbech Skov, et al.
Nature
|
November 8, 2016
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Daniel P Dever, Rasmus O Bak, Andreas Reinisch, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 25, 2013
IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication
Martin R Jakobsen, Rasmus O Bak, Annika Andersen, et al.
Nature Communications
|
August 12, 2025
Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease
Jonas Holst Wolff, Thomas Wisbech Skov, Didde Haslund, et al.
Nature Communications
|
September 8, 2019
Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
Natalia Gomez-Ospina, Samantha G Scharenberg, Nathalie Mostrel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 31, 2025
Treatment of GATA2 deficiency by allele-specific CRISPR-Cas9-directed gene correction in hematopoietic stem cells
Thomas Wisbech Skov, Jonas Holst Wolff, Didde Haslund, et al.
Iscience
|
May 28, 2019
CRISPR/Cas9 Genome Engineering in Engraftable Human Brain-Derived Neural Stem Cells
Daniel P Dever, Samantha G Scharenberg, Joab Camarena, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 85) with videos related to
Sort By:
Page
of 9
Nature Communications
|
March 7, 2024
CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expression
Huiqiang Cai, Bin Zhang, Johanne Ahrenfeldt, et al.
Nature Biotechnology
|
June 30, 2015
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
Ayal Hendel, Rasmus O Bak, Joseph T Clark, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 15, 2018
Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34<sup>+</sup> Hematopoietic Stem and Progenitor Cells
M Kyle Cromer, Sriram Vaidyanathan, Daniel E Ryan, et al.
Nucleic Acids Research
|
August 14, 2025
Gene editing in hematopoietic stem cells by co-delivery of Cas9/sgRNA ribonucleoprotein and templates for homology-directed repair in 'all-in-one' lentivirus-derived nanoparticles
Sofie Andersen, Jonas Holst Wolff, Thomas Wisbech Skov, et al.
Nature
|
November 8, 2016
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Daniel P Dever, Rasmus O Bak, Andreas Reinisch, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 25, 2013
IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication
Martin R Jakobsen, Rasmus O Bak, Annika Andersen, et al.
Nature Communications
|
August 12, 2025
Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease
Jonas Holst Wolff, Thomas Wisbech Skov, Didde Haslund, et al.
Nature Communications
|
September 8, 2019
Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
Natalia Gomez-Ospina, Samantha G Scharenberg, Nathalie Mostrel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 31, 2025
Treatment of GATA2 deficiency by allele-specific CRISPR-Cas9-directed gene correction in hematopoietic stem cells
Thomas Wisbech Skov, Jonas Holst Wolff, Didde Haslund, et al.
Iscience
|
May 28, 2019
CRISPR/Cas9 Genome Engineering in Engraftable Human Brain-Derived Neural Stem Cells
Daniel P Dever, Samantha G Scharenberg, Joab Camarena, et al.
Page
of 9